Insider · CIK 0001773661
Edward M Basile
Files at TMDX (TransMedics Group, Inc.). First filing Nov 7, 2024, latest Oct 31, 2025.
In brief
Edward M Basile files SEC Form 4 as director at TMDX (TransMedics Group, Inc.). Since Nov 7, 2024, Edward M Basile has reported 0 open-market buys worth $0 and 5 open-market sells worth $3.0M, the latest filed on Oct 31, 2025.
A track record needs three past buys with six months of prices behind them; Edward M Basile has 0, so none is measured yet.
The newest scored trade: sold $540k of TMDX on Oct 29, 2025, filed Oct 31, 2025, scored 19 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $540k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TMDX: TransMedics Group, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 19Weak | TransMedics Group, Inc. | $540k 4,142 shares | -59% | +137% from low-6% from high | |
| 18Weak | TransMedics Group, Inc. | $520k 4,143 shares | -59% | +127% from low-23% from high | |
| 35Weak | TransMedics Group, Inc. | $632k 5,000 shares | -64% | +127% from low-23% from high | |
| 29Weak | TransMedics Group, Inc. | $694k 6,000 shares | -89% | +97% from low-33% from high | |
| 27Weak | TransMedics Group, Inc. | $564k 6,750 shares | -90% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 29, 2025 | TMDX TRANSMEDICS GROUP, INC. | 4,142 0.01% of outstanding | $540k | Oct 29, 2025 | $520k |
| Aug 4, 2025 | TMDX TRANSMEDICS GROUP, INC. | 4,143 0.01% of outstanding | $520k | Aug 4, 2025 | $1.3M |
| May 27, 2025 | TMDX TRANSMEDICS GROUP, INC. | 5,000 0.01% of outstanding | $632k | May 27, 2025 | $694k |
| May 9, 2025 | TMDX TRANSMEDICS GROUP, INC. | 6,000 0.02% of outstanding | $694k | May 9, 2025 | none |
| Nov 5, 2024 | TMDX TRANSMEDICS GROUP, INC. | 6,750 0.02% of outstanding | $564k | Nov 5, 2024 | $1.0M |
| Feb 6, 2024 | TMDX TRANSMEDICS GROUP, INC. | 7,157 0.02% of outstanding | $618k | Feb 6, 2024 | none |
Transactions
Every row this insider has filed, 18 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | TMDX TransMedics Group, Inc. | AGrant or award Common Stock10b5-1 | +2,922 | $0.00 | $0 | 5,788 | May 22, 2026 |
| Oct 29, 2025 | TMDX TransMedics Group, Inc. | MOption exercise Common Stock10b5-1 | +4,142 | $0.70 | $2,899 | 7,008 | Oct 31, 2025 |
| Oct 29, 2025 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -4,142 | $130.45 | $540k | 2,866 | Oct 31, 2025 |
| Oct 29, 2025 | TMDX TransMedics Group, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,142 | - | - | 0 | Oct 31, 2025 |
| Aug 4, 2025 | TMDX TransMedics Group, Inc. | MOption exercise Common Stock10b5-1 | +4,143 | $0.70 | $2,900 | 7,009 | Aug 5, 2025 |
| Aug 4, 2025 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -4,143 | $125.51 | $520k | 2,866 | Aug 5, 2025 |
| Aug 4, 2025 | TMDX TransMedics Group, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -4,143 | - | - | 4,142 | Aug 5, 2025 |
| May 27, 2025 | TMDX TransMedics Group, Inc. | MOption exercise Common Stock10b5-1 | +5,000 | $0.70 | $3,500 | 7,866 | May 29, 2025 |
| May 27, 2025 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -5,000 | $126.45 | $632k | 2,866 | May 29, 2025 |
| May 27, 2025 | TMDX TransMedics Group, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -5,000 | - | - | 8,285 | May 29, 2025 |
| May 22, 2025 | TMDX TransMedics Group, Inc. | AGrant or award Common Stock | +2,134 | $0.00 | $0 | 2,866 | May 23, 2025 |
| May 9, 2025 | TMDX TransMedics Group, Inc. | MOption exercise Common Stock10b5-1 | +6,000 | $0.70 | $4,200 | 6,732 | May 13, 2025 |
| May 9, 2025 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -6,000 | $115.63 | $694k | 732 | May 13, 2025 |
| May 9, 2025 | TMDX TransMedics Group, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,000 | - | - | 13,285 | May 13, 2025 |
| Nov 5, 2024 | TMDX TransMedics Group, Inc. | MOption exercise Common Stock10b5-1 | +6,750 | $28.12 | $190k | 7,482 | Nov 7, 2024 |
| Nov 5, 2024 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -5,296 | $83.35 | $441k | 2,186 | Nov 7, 2024 |
| Nov 5, 2024 | TMDX TransMedics Group, Inc. | SOpen-market sale Common Stock10b5-1 | -1,454 | $84.30 | $123k | 732 | Nov 7, 2024 |
| Nov 5, 2024 | TMDX TransMedics Group, Inc. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -6,750 | $0.00 | $0 | 0 | Nov 7, 2024 |
Questions about Edward M Basile
Answered from the filings on this page, as of the latest one.
Is Edward M Basile buying or selling?
In the last 12 months Edward M Basile reported 0 open-market buys worth $0 and 1 open-market sell worth $540k on SEC Form 4; the latest was sold $540k of TMDX on Oct 29, 2025. Grants, option exercises and tax withholding are not counted.
How did Edward M Basile's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Edward M Basile has 0.
Where does Edward M Basile file Form 4?
Edward M Basile has filed Form 4 at TMDX (TransMedics Group, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.